1. Home
  2. ARCB vs GPCR Comparison

ARCB vs GPCR Comparison

Compare ARCB & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ArcBest Corporation

ARCB

ArcBest Corporation

HOLD

Current Price

$122.36

Market Cap

2.8B

Sector

Industrials

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$38.79

Market Cap

2.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARCB
GPCR
Founded
1923
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
1994
2023

Fundamental Metrics

Financial Performance
Metric
ARCB
GPCR
Price
$122.36
$38.79
Analyst Decision
Buy
Strong Buy
Analyst Count
12
12
Target Price
$122.75
$103.17
AVG Volume (30 Days)
325.4K
772.9K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
0.38%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,657,864,000.00
N/A
Revenue This Year
$7.00
N/A
Revenue Next Year
$5.80
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.56
N/A
52 Week Low
$59.43
$15.80
52 Week High
$135.10
$94.90

Technical Indicators

Market Signals
Indicator
ARCB
GPCR
Relative Strength Index (RSI) 58.85 32.35
Support Level $115.28 $30.82
Resistance Level $135.10 $40.29
Average True Range (ATR) 5.50 2.34
MACD -1.23 0.06
Stochastic Oscillator 50.91 16.92

Price Performance

Historical Comparison
ARCB
GPCR

About ARCB ArcBest Corporation

ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: